Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry.

Aldo Pietro MaggioniAndrew L ClarkVivencio BarriosThibaud DamyJaroslaw DrozdzCandida FonsecaLars H LundStefanie KalusPhilippe C FerberRizwan I HussainCornelia KochUwe Zeymernull null

Published in: ESC heart failure (2022)

This large HFrEF European registry provides a contemporary outcome profile of outpatients with HFrEF treated with or without sacubitril/valsartan. In a real-world setting, sacubitril/valsartan was associated with an improvement of symptoms in patients with HFrEF compared with the conventional HFrEF treatment.

Keyphrases

ejection fraction
heart failure
left ventricular
type diabetes
atrial fibrillation
adipose tissue
metabolic syndrome
sleep quality
depressive symptoms
skeletal muscle